Brief: ESSA Pharma To Adjourn Special Meeting To September 29, 2025
Sept 10 (Reuters) - ESSA Pharma Inc EPIX.O: ESSA PHARMA INC - TO ADJOURN SPECIAL MEETING TO SEPTEMBER 29, 2025 ESSA PHARMA INC - ADJOURNMENT FOR DISCUSSIONS ON REVISED TERMS WITH XENOTHERAPEUTICS Source text: ID:nPn1hzDPDa Further company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics